Zobrazeno 1 - 10
of 150
pro vyhledávání: '"Erik A. Ranheim"'
Publikováno v:
Journal of Pathology and Translational Medicine, Vol 57, Iss 2, Pp 123-127 (2023)
Systemic Epstein-Barr virus (EBV)–positive T-cell lymphoma of childhood (SETLC) is a rare, rapidly progressive, and often fatal disease of children and young adults characterized by monoclonal expansion of EBV-positive T cells in tissues or periphe
Externí odkaz:
https://doaj.org/article/fae7647b5a604dc3baf002afed13dcb4
Autor:
Amy K. Erbe, Wei Wang, Lakeesha Carmichael, Anna Hoefges, Bartosz Grzywacz, Patrick K. Reville, Erik A. Ranheim, Jacquelyn A. Hank, KyungMann Kim, Songwon Seo, Eneida A. Mendonca, Yiqiang Song, Vaishalee P. Kenkre, Fangxin Hong, Randy D. Gascoyne, Elisabeth Paietta, Sandra J. Horning, Jeffrey S. Miller, Brad Kahl, Paul M. Sondel
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-12 (2019)
Abstract Background The ECOG-ACRIN Cancer Research Group evaluated rituximab treatment schedules for patients with newly-diagnosed low-tumor-burden follicular-lymphoma (FL). All patients received 4-weekly rituximab treatments as induction therapy. Cl
Externí odkaz:
https://doaj.org/article/56d8bd49a94b4312b631a820fc45bb9c
Autor:
Kran Suknuntha, Yoon Jung Choi, Ho Sun Jung, Aditi Majumder, Sujal Shah, Igor Slukvin, Erik A. Ranheim
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Numerous recurrent genetic mutations are known to occur in acute myeloid leukemia (AML). Among these common mutations, Fms-like tyrosine kinase 3 remains as one of the most frequently mutated genes in AML. We observed apparent marrow expansion of meg
Externí odkaz:
https://doaj.org/article/ebfe2063324f4cfc82b1e0a88ad7bbc8
Autor:
Charu Mehta, Kirby D. Johnson, Xin Gao, Irene M. Ong, Koichi R. Katsumura, Skye C. McIver, Erik A. Ranheim, Emery H. Bresnick
Publikováno v:
Cell Reports, Vol 20, Iss 12, Pp 2966-2979 (2017)
Hematopoietic development requires the transcription factor GATA-2, and GATA-2 mutations cause diverse pathologies, including leukemia. GATA-2-regulated enhancers increase Gata2 expression in hematopoietic stem/progenitor cells and control hematopoie
Externí odkaz:
https://doaj.org/article/5f5db142b9614d63809ec53cb53732d3
Autor:
Xin Gao, Tongyu Wu, Kirby D. Johnson, Jamie L. Lahvic, Erik A. Ranheim, Leonard I. Zon, Emery H. Bresnick
Publikováno v:
Stem Cell Reports, Vol 6, Iss 3, Pp 368-382 (2016)
Hematopoietic stem cells (HSCs) originate from hemogenic endothelium within the aorta-gonad-mesonephros (AGM) region of the mammalian embryo. The relationship between genetic circuits controlling stem cell genesis and multi-potency is not understood.
Externí odkaz:
https://doaj.org/article/4aed63eb101d42448f4a2ba262a9e5bc
Publikováno v:
Case Reports in Hematology, Vol 2013 (2013)
Posttransplant lymphoproliferative disorder (PTLD) comprises a spectrum ranging from polyclonal hyperplasia to aggressive monoclonal lymphomas. The majority of PTLDs are of B-cell origin while T-cell PTLDs and Hodgkin lymphoma-like PTLDs are uncommon
Externí odkaz:
https://doaj.org/article/1684fac4908a40dbbe7e715d3c21e4f8
Autor:
Paul M. Sondel, Javed Khan, Mark R. Albertini, KyungMann Kim, Renae Quale, Zachary S. Morris, Amy K. Erbe, Cindy Zuleger, Jacquelyn A. Hank, Viharkumar Patel, Young K. Song, Vineela Gangalapudi, Berkley E. Gryder, Sivasish Sindiri, Jun S. Wei, Erik A. Ranheim, Igor B. Kuznetsov, Richard K. Yang
Expression of Many Interleukins (IL) Prognosticates Favorable Survival in Group A and Group B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b898c43917e799114d194fcd0db19c45
https://doi.org/10.1158/1078-0432.22476389
https://doi.org/10.1158/1078-0432.22476389
Autor:
Brad S. Kahl, Julie E. Chang, Terrence P. Cescon, Jane N. Winter, Timothy E. O'Brien, Philip A. Dy, Puneet Singh Cheema, Stephen M. Ansell, Erik A. Ranheim, Andrew Quon, Thomas E. Witzig, Randy D. Gascoyne, Ranjana H. Advani, Thomas M. Habermann, Fangxin Hong, Andrew M. Evens
Supplemental Tables 1-9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0a1037779ccf654dcbeee0a061dde62
https://doi.org/10.1158/1078-0432.22477346
https://doi.org/10.1158/1078-0432.22477346
Autor:
Brad S. Kahl, Julie E. Chang, Terrence P. Cescon, Jane N. Winter, Timothy E. O'Brien, Philip A. Dy, Puneet Singh Cheema, Stephen M. Ansell, Erik A. Ranheim, Andrew Quon, Thomas E. Witzig, Randy D. Gascoyne, Ranjana H. Advani, Thomas M. Habermann, Fangxin Hong, Andrew M. Evens
Purpose:We sought to improve upon frontline bendamustine/rituximab (BR) induction therapy followed by rituximab maintenance in untreated high-risk follicular lymphoma (FL).Patients and Methods:Patients were randomized to BR induction followed by 2-ye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::360ee251e8485fcb00e39c958d72ee2f
https://doi.org/10.1158/1078-0432.c.6529628
https://doi.org/10.1158/1078-0432.c.6529628
Autor:
Paul M. Sondel, Javed Khan, Mark R. Albertini, KyungMann Kim, Renae Quale, Zachary S. Morris, Amy K. Erbe, Cindy Zuleger, Jacquelyn A. Hank, Viharkumar Patel, Young K. Song, Vineela Gangalapudi, Berkley E. Gryder, Sivasish Sindiri, Jun S. Wei, Erik A. Ranheim, Igor B. Kuznetsov, Richard K. Yang
The Majority of Immunologic Gene Signatures Significantly Predict RFS and OS in Group A, but not in Group B.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c030851aafae76166e312c5b01a4bf8a
https://doi.org/10.1158/1078-0432.22476407.v1
https://doi.org/10.1158/1078-0432.22476407.v1